Real-world cardiovascular toxicity of immune checkpoint inhibitors in an asian population: insights from a nationwide taiwanese registry
Immune checkpoint inhibitors (ICIs) have revolutionized oncologic treatment but are increasingly recognized to be associated with immune-related cardiovascular (CV) toxicities. While most epidemiological data were derived from Western populations, comprehensive real-world data from Asian cohorts remain limited. T...